Medication Effects That May Impair Driving Ability

Slides:

Advertisements

Similar presentations

Introduction to Drugs. Drugs in America Is there a problem? National Drug Control Strategy Plan to decrease drug use and availability in half in 10 yrs.

Advertisements

At Risk and Dependent Drinking: Scope of the Problem.

National Overdose Deaths Number of Deaths from Prescription Drugs.

Transportation Safety & Potentially Sedating or Impairing Medications Jenny Bergin The Pharmacy Guild of Australia The Australian Regulatory & Professional.

Copyright © 2015 Cengage Learning® 1 Chapter 19 Analgesics, Sedatives, and Hypnotics.

Personal Factors That Affect Driving. Personal Factors Include: Alcohol, Drugs, and Fatigue.

Copyright Alcohol Medical Scholars Program1 Medical Consequences of Alcohol and Drug Use Disorders Eric B. Raimo, M.D.

The Latest Prescription Trends for Controlled Prescription Drugs

Kathleen J. Farkas, PhD Case Western Reserve University, Mandel School of Applied Social Sciences Laurie Drabble, PhD San Jose State University, School.

Prescription Drug Monitoring Presented by: Len Abbott, Ph.D. Director Science and Technology Kathleen Valentine, General Manager PDM & Toxicology May 14,

Addiction vs. Physical Dependence Katie Ulrich Clinical Psychologist.

PRESCRITION DRUG ABUSE and the ELDERLY GREGORY BUNT, M.D. Clinical Assistant Professor of Psychiatry NYU School of Medicine Interim Medical Director Samaritan.

HANDLING SOCIAL PRESSURES

Introduction and Overview

Poly-substance Impaired Drivers

Multimodal Management of Opioid-Induced Constipation

Among People with High Financial Burdens, Prescription Drug Expenses Compose the Largest Share of Out-of-Pocket Costs for Those with Chronic Conditions.

THE OPIOID CRISIS Mississippi Board of Nursing

Substance Use and Aging

A Recommendation from Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from ACOP and APS By Rhys Dela Cruz, Angela Hickey,

Prevention Strategies for Young Adults and Higher Education

Talking to Patients About HCV Treatment

Primary Care Challenges in Depression - To Treat or Refer?

CANNABIS AND CANNABINOIDS: THE CONUNDRUM

Managing Women Living With HIV Infection

Starting Strong: Initial Evaluation of the Patient With HCV

Omega-3 Prescriptions vs Supplements in Practice

Optimizing Therapy for Osteoarthritis

Medicine and Illegal Drugs Unit

The European Experience: Prescription Drug Misuse in France, Germany, Italy and Spain 24 October 2017 Presented at Lisbon Addictions 2017 Jody L. Green,

This program will include a discussion of off-label treatment and devices and investigational agents and devices not approved by the FDA for use in the.

Cognition and the Older Driver

Introduction ESC Annual Meeting in Review: NOACs and NVAF: Real-World Data, Guidelines, and More.

Moderate-Intensity Statins for Dyslipidemia: How to Treat Today?

Differentiating Drug-Seeking Behavior From Poorly Controlled Pain

Managing Complex Hypertension: What Every Physician Should Know

Patient-Centered Care in Cystic Fibrosis

AAA Drugged Driving Summit│ January 26, 2015 │ Tampa, FL

Introduction. Risk Communication With Patients: Your Guide to Resources and Recommendations.

Understanding Statin Metabolism

More Than Treatment.

Panelists. One Size May Not Fit All: A New Aspirin Option for the High-Risk Patient.

Lessons Learned In Opioid Treatment From the Pain Action Consulting Team.

Introduction. Family Planning and Pregnancy Management in Patients With Chronic Inflammatory Rheumatic Diseases.

Case Study. Managing Medication and Adherence in SIHD: Partnering With the Patient to Improve Care.

Introduction. A Reality Check on BP Goals and Optimizing Patient Adherence to Treatment.

Managing Depression is a Team Effort:

Avoiding Opioid Overuse: Guideline-Based Management of Osteoarthritis

OTC NSAID Use in Patients With OA and CV Disease

From Start to Finish: Initial and Ongoing Care for Men Receiving PrEP

Battling Constipation

An Interprofessional Perspective on the Safe and Appropriate Use of Opioid Analgesics.

Hidden in Plain Sight: Disrupted Sleep in Patients With Pain

PrEP Ongoing Care.

Medication Risks for Older Drivers

THE TRUTH ABOUT MODERN OBESITY AGENTS: ARE THEY REALLY SAFE AND EFFECTIVE?

Managing Pain in the 21st Century

Prevalence of BZD & Other Respiratory Depressing Agents, n=58

Persistent pain management An update

Drugs Health 7 Name: Grade: 70__.

Adults with Health Problems Who Have an Excellent Patient Experience Are Most Likely to Be Well-Informed About Their Prescription Medications Percent of.

The Clinical Implications of Cytochrome P450 Interactions With Opioids and Strategies for Pain Management Michael J. Brennan, MD Journal of Pain and.

Championing Evidence-Based Care in Patients With Acute Low Back Pain

Introduction. Welcome to this program, titled De-Escalating Therapy in Epilepsy: A Return to Monotherapy.

Jim Messina, Ph.D., CCMHC, NCC, DCMHS-T

Medically assisted treatment

Center for Behavioral Health Statistics and Quality

Multimodal Approaches to Cracking the Code in Low Back Pain

Presentation transcript:

Medication Effects That May Impair Driving Ability

Introduction

Scope of the Problem

National Roadside Survey Results

PDI Medications

PDI Medications (cont)

Drug-Related AEs

Benzodiazepines and Hypnotics

Melatonin vs Zolpidem

NSAIDs

Teens/Young Adults and Prescription Drugs

Opioid Use in the Opioid-Naïve

Tramadol and Buprenorphine

Opioids for Acute Pain

Chronic Use: Opioid-Tolerant Patients

Precautions While Building Opioid Tolerance

AEs of OTC Antihistamines/Cough Medications

Other OTC Medication Concerns

Driving Effects and BAC Level

Alcohol-Medication Interactions

Cocaine and Other Drugs

Ecstasy and Amphetamines

Marijuana

DUI Among Young Drivers

Drug Combinations/Polypharmacy

Patient Counseling and Education

Pharmacist Counseling

Primary Care Provider Recommendations

Risk Reduction Strategies

Additional Resources

Conclusions

Conclusions (cont)

Abbreviations